Mark D. Reeth, General Counsel&VP Corporate Compliance at SALIX PHARMACEUTICALS LTD (SLXP), sold 4,278 shares at $36.24 ($155K) on 2010-06-14, disclosed to the SEC on 2010-06-15.
Scheduled sale ($155k) by General Counsel&VP Corporate Compliance under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| SLXP | SELL | 2011-05-17 | $135K | — | Filing → |
| SLXP | SELL | 2010-05-19 | $126K | — | Filing → |
| SLXP | SELL | 2009-11-24 | $80K | — | Filing → |